The current study is among the first to show a greater impact of exposure to the COVID-19 pandemic on levels of maternal and infant methylation of target stress-related genes (i.e., NR3C1 and SLC6A4) in late gestation, as compared to earlier exposures. The gene discussed is NR3C1; the disease is COVID-19.